Skip to content
Home/Companies/MedTech/Creative Specific Software (C2S / VA2CS)

Creative Specific Software (C2S / VA2CS)

MedTech·France·Active·8yr hold
Entry
2018
Hold
8yr
Status
Active

Who owns Creative Specific Software (C2S / VA2CS)?

Creative Specific Software (C2S / VA2CS) is currently owned by UI Investissement through Cap Autrement (2023 vintage), since 2018.

Hand-verified · updated 2026-04-21

UI Investissement
Investor
UI Investissement
Cap Autrement · 2023 · Growth

Key facts

HQFrance
SectorMedTech

More from Cap Autrement

Other portfolio companies in the same fund.

Didactic
Didactic
Active
MedTechFrance· 2024
Forex Finance
Active
FinancialsFrance· 2024
Groupe VIT
Active
ConstructionFrance· 2024
Lify Air
Active
MedTechFrance· 2024
LoValTech
Active
BiotechTours, France· 2024
Agriwatt
Active
ClimateTechFrance· 2023

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue